PD-L1 has been extensively described as the membrane-bound ligand of PD-1. A recent study discovered a previously unknown role for PD-L1, which is able to bind DNA and thus govern different pathways linked to either evasion of immune surveillance or tumour microenvironment inflammation.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
PD-L1 regulates c-MET phosphorylation and contributes to MET-dependent resistance to osimertinib in EGFR-mutant NSCLC
Journal of Biomedical Science Open Access 09 October 2025
-
Lysosomes: guardians and healers within cells- multifaceted perspective and outlook from injury repair to disease treatment
Cancer Cell International Open Access 09 April 2025
-
Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibition
Cancer Cell International Open Access 16 September 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout

References
Baumeister, S. H., Freeman, G. J., Dranoff, G. & Sharpe, A. H. Annu. Rev. Immunol. 34, 539–573 (2016).
Li, X. et al. Nat. Rev. Clin. Oncol. 16, 425–441 (2019).
Galluzzi, L., Chan, T. A., Kroemer, G., Wolchok, J. D. & López-Soto, A. Sci. Transl. Med. Rev. 10, eaat7807 (2018).
Azuma, T. et al. Blood 111, 3635–3643 (2008).
Chang, C. H. et al. Cell 162, 1229–1241 (2015).
Chen, N. et al. J. Thorac. Oncol. 10, 910–923 (2015).
Tu, X. et al. Mol. Cell 74, 1215–1226.e4 (2019).
Song, H. et al. Biochem. Biophys. Res. Commun. 404, 68–73 (2011).
Gao, Y. et al. Nat. Cell Biol. https://doi.org/10.1038/s41556-020-0562-4 (2020).
Yoo, C. B. & Jones, P. A. Nat. Rev. Drug Discov. 5, 37–50 (2006).
von Burstin, J. et al. Gastroenterology 137, 361–371 (2009).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Jaccard, A., Ho, PC. The hidden side of PD-L1. Nat Cell Biol 22, 1031–1032 (2020). https://doi.org/10.1038/s41556-020-0568-y
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41556-020-0568-y
This article is cited by
-
Lysosomes: guardians and healers within cells- multifaceted perspective and outlook from injury repair to disease treatment
Cancer Cell International (2025)
-
PD-L1 regulates c-MET phosphorylation and contributes to MET-dependent resistance to osimertinib in EGFR-mutant NSCLC
Journal of Biomedical Science (2025)
-
Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibition
Cancer Cell International (2023)